RADIOTHERAPY AND ONCOLOGY

Scope & Guideline

Shaping the future of cancer treatment through peer-reviewed excellence.

Introduction

Explore the comprehensive scope of RADIOTHERAPY AND ONCOLOGY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore RADIOTHERAPY AND ONCOLOGY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0167-8140
PublisherELSEVIER IRELAND LTD
Support Open AccessNo
CountryIreland
TypeJournal
Convergefrom 1983 to 2024
AbbreviationRADIOTHER ONCOL / Radiother. Oncol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE 00000, IRELAND

Aims and Scopes

The journal 'Radiotherapy and Oncology' focuses on advancing the field of radiation therapy through rigorous research and innovation. It encompasses a wide range of topics related to radiotherapy in oncology, including clinical applications, technological advancements, and the biological effects of radiation. The journal aims to disseminate findings that can improve patient outcomes and enhance the efficacy of radiotherapy treatments.
  1. Clinical Radiotherapy Techniques:
    The journal publishes studies on various radiotherapy techniques, including intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), and brachytherapy. Research in this area focuses on optimizing treatment plans, improving delivery methods, and assessing patient outcomes.
  2. Radiobiology and Treatment Response:
    It covers the biological effects of radiation on cancer cells and surrounding tissues. This includes studies on dose-response relationships, mechanisms of radioresistance, and the role of biomarkers in predicting treatment efficacy.
  3. Technological Innovations in Radiotherapy:
    The journal highlights advancements in radiotherapy technology, such as MR-guided therapy, artificial intelligence applications in treatment planning, and the development of new imaging techniques to improve accuracy and precision in radiation delivery.
  4. Quality Assurance and Safety in Radiotherapy:
    Research related to quality assurance processes, patient safety protocols, and the implementation of best practices in radiotherapy settings is a significant focus area, aiming to minimize errors and enhance treatment quality.
  5. Patient-Reported Outcomes and Quality of Life:
    The journal emphasizes the importance of patient-reported outcomes and quality of life assessments in cancer treatment. It aims to understand the impact of radiotherapy on patients' physical, emotional, and social well-being.
  6. Palliative Care and Symptom Management:
    It addresses the role of radiotherapy in palliative care settings, exploring its effectiveness in managing symptoms and improving the quality of life for patients with advanced cancer.
The journal has identified several emerging themes and trends in radiation oncology, reflecting the evolving landscape of research and clinical practice. These areas are gaining attention and are likely to shape the future of radiotherapy.
  1. Artificial Intelligence in Radiotherapy:
    There is a significant increase in research exploring the application of artificial intelligence (AI) in various aspects of radiotherapy, including treatment planning, image analysis, and patient-specific quality assurance. AI's potential to enhance precision and efficiency in radiation therapy is a major focus.
  2. Personalized and Adaptive Radiotherapy:
    Emerging studies emphasize the need for personalized treatment approaches, including adaptive radiotherapy that adjusts for anatomical changes over the course of treatment, aiming to optimize therapeutic outcomes and minimize toxicity.
  3. Integration of Immunotherapy with Radiotherapy:
    Research is increasingly focusing on the synergistic effects of combining immunotherapy with radiotherapy, investigating how these modalities can enhance treatment response and improve patient survival rates.
  4. Longitudinal Patient-Reported Outcomes:
    There is a growing emphasis on longitudinal studies assessing patient-reported outcomes (PROs) and quality of life, recognizing the importance of these metrics in evaluating the overall effectiveness of radiotherapy.
  5. Radiomics and Biomarker Development:
    The trend towards utilizing radiomics—extracting large amounts of features from medical images—and developing predictive biomarkers for treatment response is gaining momentum, with potential applications in personalized treatment strategies.
  6. Sustainability and Cost-Effectiveness in Radiotherapy:
    Emerging research focuses on the sustainability of radiotherapy practices and the economic evaluation of treatment strategies, aiming to balance efficacy with cost-effectiveness in healthcare delivery.

Declining or Waning

While 'Radiotherapy and Oncology' continues to expand its horizons, certain areas of focus have shown a decline in publication frequency or prominence. These waning themes reflect shifting research priorities and advancements in the field.
  1. Traditional Radiotherapy Techniques:
    There has been a noticeable decline in studies focusing solely on conventional radiotherapy techniques, such as 2D planning and standard fractionation, as newer, more advanced methods gain traction in clinical practice.
  2. Single-Agent Radiotherapy Studies:
    Research that investigates the effects of radiotherapy as a standalone treatment has seen a decrease. There is a growing emphasis on combination therapies, particularly integrating radiotherapy with immunotherapy or targeted therapies.
  3. Basic Radiobiological Studies:
    While foundational research in radiobiology remains important, there is a shift towards more applied research that directly correlates with clinical outcomes, leading to a reduction in purely theoretical studies.
  4. Generalized Quality Assurance Protocols:
    The focus on generalized quality assurance protocols has waned in favor of more specific, customizable approaches tailored to individual patient needs and treatment plans.

Similar Journals

Onkologija

Advancing cancer research for a healthier tomorrow.
Publisher: INST ONCOLOGY LJUBLJANAISSN: 1408-1741Frequency: 2 issues/year

Onkologija is a distinguished open-access journal dedicated to the field of oncology, published by the Institute of Oncology Ljubljana. With its ISSN 1408-1741 and E-ISSN 1581-3215, this journal has become a crucial platform for researchers and healthcare professionals since its transition to open-access in 2008, allowing widespread dissemination of critical findings and innovations in cancer research and treatment. Located in Ljubljana, Slovenia, the journal aims to bridge the gap between clinical practice and research by publishing high-quality original articles, reviews, and case studies that address pivotal issues in oncology. Although specific metrics such as HIndex and Scopus ranks are currently unavailable, Onkologija’s commitment to advancing oncology knowledge is evident in its engaging publications that attract a diverse readership, making it an essential resource for anyone invested in the battle against cancer.

JOURNAL OF RADIATION RESEARCH

Bridging disciplines in the ever-evolving field of radiation research.
Publisher: OXFORD UNIV PRESSISSN: 0449-3060Frequency: 6 issues/year

JOURNAL OF RADIATION RESEARCH, published by Oxford University Press, is a prominent peer-reviewed journal focusing on the diverse fields of radiation science, including health, toxicology, and radiology. Since its inception in 1960, this open-access journal has provided a critical platform for the dissemination of high-quality research, making it accessible to a global audience of researchers, professionals, and students. With a consistent track record, the journal holds an impressive impact factor and is categorized in Q2 of Radiation studies and Q3 in Health and Toxicology as per the 2023 rankings, reflecting its influential role in shaping contemporary discourse in the field. The journal also boasts notable rankings within Scopus, further underscoring its importance in advancing knowledge and innovations related to radiation. Spanning from 1960 to 2024, the JOURNAL OF RADIATION RESEARCH remains at the forefront of scientific exploration and is essential reading for anyone committed to advancing the understanding of radiation and its effects.

ACTA ONCOLOGICA

Shaping the future of cancer treatment and research.
Publisher: Medical Journal Sweden ABISSN: 0284-186XFrequency: 12 issues/year

ACTA ONCOLOGICA is a prestigious multidisciplinary journal published by Medical Journal Sweden AB, dedicated to advancing cancer research and clinical practice. As a key resource in the field of oncology, the journal aims to publish high-quality articles that cover significant developments in cancer biology, treatment modalities, and innovative imaging techniques. With an ISSN of 0284-186X and an E-ISSN of 1651-226X, ACTA ONCOLOGICA operates in the United Kingdom and is recognized for its substantial impact, currently holding a Q2 ranking in the categories of Hematology, Medicine (miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging in 2023. The journal’s commitment to disseminating pivotal research is reflected in its inclusion in Scopus, with rankings placing it in the top half of its fields. Though it does not currently offer Open Access, it remains an essential resource for researchers, healthcare professionals, and students seeking to stay informed on the latest trends and findings in oncology. Established in 1963, the journal continues to be a cornerstone of cancer research well into 2024.

RADIATION RESEARCH

Innovative studies shaping the future of radiation science.
Publisher: RADIATION RESEARCH SOCISSN: 0033-7587Frequency: 12 issues/year

RADIATION RESEARCH is a prestigious journal published by the RADIATION RESEARCH SOC that serves as a vital resource for professionals and researchers in the fields of biophysics, radiation science, and radiology. Established in 1954, this journal has consistently advanced the study of radiation's effects on health and the environment, bridging fundamental and applied research. It boasts an impressive impact factor reflected in its quartile rankings, including Q2 in Biophysics and Q1 in Radiation, making it a highly regarded publication within its discipline. Researchers will find valuable insights through rigorous peer-reviewed articles that explore innovative methodologies and findings related to radiation exposure, imaging technologies, and the biological consequences of radiation. Although the journal does not currently offer open access, it remains a vital reference for academia and industry, fostering a deeper understanding of radiation sciences and their implications for future research and public health.

Journal of Radiotherapy in Practice

Innovating Patient Care Through Radiotherapy Research
Publisher: CAMBRIDGE UNIV PRESSISSN: 1460-3969Frequency: 4 issues/year

Journal of Radiotherapy in Practice is a peer-reviewed journal published by Cambridge University Press, focusing on the evolving field of radiotherapy and its application in clinical practice. With ISSN 1460-3969 and E-ISSN 1467-1131, this journal serves as a critical platform for researchers, clinicians, and students in oncology and radiology, providing vital insights into treatment methodologies, patient care, and innovative practices. Although indexed in Q4 quartiles for both Oncology and Radiology, Nuclear Medicine and Imaging, the journal plays an essential role in disseminating clinical findings and advancing the science of radiotherapy since its inception in 1999. Authors are encouraged to contribute their research, case studies, and reviews that align with the journal's objectives, fostering a collaborative environment for sharing knowledge. Despite its current rankings, the journal aims to enhance its impact and visibility in the scientific community, thereby enriching professional practice and patient outcomes in the realm of radiotherapy.

Journal of Contemporary Brachytherapy

Transforming patient care with evidence-based brachytherapy solutions.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1689-832XFrequency: 6 issues/year

Journal of Contemporary Brachytherapy, published by TERMEDIA PUBLISHING HOUSE LTD, is a distinguished open-access journal dedicated to advancing the field of brachytherapy within the oncology and radiology domains. Since its inception in 2009, the journal has provided a platform for researchers, clinicians, and students to share innovative findings, cutting-edge techniques, and clinical experiences, contributing significantly to evidence-based practices in cancer treatment. With an ISSN of 1689-832X and E-ISSN 2081-2841, the journal has established its presence globally, and it is indexed in Scopus, achieving a commendable standing among its peers—with rankings of #196 in Radiology, Nuclear Medicine, and Imaging and #260 in Oncology for 2023. Notably, it holds a Q3 quartile classification, reflecting its emerging influence in these critical fields. The journal is committed to open science, ensuring that research is accessible to a wide audience, which is particularly vital for the ongoing development of methodologies and the implementation of best practices in brachytherapy. Exploring topics from the technical aspects of brachytherapy procedures to patient management strategies, the Journal of Contemporary Brachytherapy is an essential resource for those looking to stay at the forefront of oncological advancements.

International Journal of Radiation Research

Pioneering Insights in Medical Radiation Applications
Publisher: IJRR-IRANIAN JOURNAL RADIATION RESISSN: 2322-3243Frequency: 4 issues/year

The International Journal of Radiation Research, published by the IJRR-IRANIAN JOURNAL RADIATION RES, serves as a critical platform for researchers and professionals in the fields of radiology, nuclear medicine, and imaging technology. Since its inception in 2003, this peer-reviewed, open-access journal has focused on disseminating significant findings and advancements, contributing to the global discourse on radiation research. With an ISSN of 2322-3243, the journal offers valuable insights into emerging technologies and methodologies, maintaining a commitment to enhancing the understanding and application of radiation in medical science. Although currently positioned in the Q4 category across its scopes, the journal strives to elevate its impact by promoting high-quality research and innovative practices. The journal is accessible to a wide audience and encourages submissions from scholars worldwide, directly supporting the advancement of knowledge in radiological and ultrasound technology. For those seeking to explore and contribute to this dynamic field, the International Journal of Radiation Research represents an invaluable resource.

Reports of Practical Oncology and Radiotherapy

Connecting clinicians and researchers for impactful findings.
Publisher: VIA MEDICAISSN: 1507-1367Frequency: 6 issues/year

Reports of Practical Oncology and Radiotherapy is a distinguished open-access journal dedicated to advancing the fields of oncology, radiotherapy, and cancer research. Published by VIA MEDICA since 2001, this journal serves as a critical platform for disseminating innovative research and practical findings that impact clinical practices and patient outcomes. With an emphasis on fostering collaboration and knowledge exchange among researchers, clinicians, and students, the journal has positioned itself within the Q3 and Q4 categories of renowned directories in oncology, radiology, and nuclear medicine as of 2023. Based in Gdansk, Poland, it provides unrestricted access to its articles, ensuring that crucial research reaches a wide audience. This dedication to open access reflects the journal's commitment to transparency and innovation in the fight against cancer, making it an invaluable resource in this vital field of study.

Radiation Oncology Journal

Empowering oncology professionals with cutting-edge findings.
Publisher: KOREAN SOC THERAPEUTIC RADIOLOGY & ONCOLOGYISSN: 2234-3156Frequency: 4 issues/year

Radiation Oncology Journal, published by the Korean Society of Therapeutic Radiology & Oncology, stands at the forefront of cancer treatment research and innovation within the dynamic fields of oncology and radiology. With a focus on disseminating groundbreaking findings and advancements from 2012 to 2024, this journal aims to foster collaboration among researchers, clinicians, and educators dedicated to improving therapeutic techniques and patient outcomes in the context of radiation therapy. Recognized with a prestigious Q2 ranking in both the Oncology and Radiology, Nuclear Medicine and Imaging categories, it ranks 140th out of 333 in its Scopus category for Medicine Radiology and boasts a 58th percentile placement. While operating on a non-open access basis, the journal remains committed to providing valuable insights and updates to professionals in the field from its base in South Korea. As the landscape of cancer treatment evolves, the Radiation Oncology Journal continues to play a vital role in shaping research trends and enhancing the understanding of radiotherapy's role in comprehensive cancer care.

Practical Radiation Oncology

Advancing the Frontiers of Radiation Oncology
Publisher: ELSEVIER SCIENCE INCISSN: 1879-8500Frequency: 6 issues/year

Practical Radiation Oncology is a premier journal published by Elsevier Science Inc., focusing on the critically important fields of Oncology and Radiology, Nuclear Medicine, and Imaging. With an ISSN of 1879-8500, this journal serves as an essential resource for professionals and researchers dedicated to advancing the practice and research of radiation oncology. Established in 2011 and continuing through 2024, it has quickly gained recognition, achieving a prestigious Q2 ranking in Oncology and an exceptional Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. The journal, housed in New York, USA, provides a platform for innovative research and practical insights, aimed at enhancing therapeutic practices and improving patient outcomes. As part of its commitment to fostering scientific dialogue, it also features a range of articles, reviews, and clinical studies that cater to the diverse interests of its readers. Hard-copy availability combined with digital access ensures a broad reach for the latest advancements in the field.